INJURY POTENTIAL - COL1A1 G>T, COL5A1 C>T, GDF5 C>T, RECOVERY - IL6 G>C, IL6R A>C, CRP G>A, TNFA G>A, SOD2 C>T, eNOS G>T, TRAINING PROGRAMME - AGT T>C, ACE I>D, BDKRB2 C>T, VEGF C>G, NRF2 A>G, PPARGC1A G>A, PPARA G>C, ADRB2 Arg16Gly A>G, ADRB2 Gln27Glu C>G, TRHR C>T, ACTN3 R>X, VDR T>C, PEAK TRAINING TIME - CLOCK3111 T>C, MUSCLE CRAMPING SUSCEPTIBILITY - AMPD1 G>A, CAFFEINE METABOLISM - CYP1A2 C>A, PRESSURE RESPONSE - COMT 472 G>A, SATURATED FATS - FABP2 Ala54Thr G>A, ADIPOQ -11391 G>A, PPARG Pro12Ala C>G, APOA2 265 T>C, TCF7L2 C>T, FTO T>A, APOA5 1131 T>C, PLIN 11482 G>A, MC4R V103I T>C, TNFA -308 G>A, CARBOHYDRATES - ADIPOQ -11391 G>A, ADBR2 Gln27Glu C>G, DRD2 C>T, TAS1R2 Ile191Val G>A, SLC2A2 Thr110Ile C>T, EXERCISE FOR WEIGHT MANAGEMENT - ADBR2 Arg16Gly C>G, ADBR2 Gln27Glu C>G, ADRB3 Trp64Arg T>C, FTO T>A, PPARG Pro12Ala C>G, MONO-UNSATURATED FATS - FABP2 Ala54Thr G>A, ADIPOQ -11391 G>A, POLY-UNSATURATED FATS - PPARG Pro12Ala C>G, FTO T>A, PROTEIN - FTO T>A,

Alopecia Areata - HLA Risk Genotypes (HLA Class II: DRB1*04:01, DRB1*16), HLA Protective Genotypes (HLA Class II: DRB1*03, DRB1*09, DRB1*13), Ankylosing Spondylitis (AS) - HLA Risk Genotypes (HLA Class I: B*27:05, B*27:04, B*27:02, B*27:07), HLA Protective Genotypes (HLA Class I: B*27:06, B*27:09), Coeliac Disease (CD) - HLA Class II: (DQA1*05, 05 with DQB1*02, 02, DQA1*05 with DQB1*02, DQA1*03 with DQB1*03:02, DQA1*02 with DQB1*02, DQA1*05 with DQB1*03:01), Graves’ Disease (GD) - HLA Risk Genotypes (HLA Class I: B*08, B*35:01, B*46:01, C*07), (HLA Class II: DRB1*03, DQA1*05, DPB1*05:01, DRB1*08, DRB1*14:03, DRB1*15:01, DRB1*16:02, DRB3*02:02), HLA Protective Genotypes (HLA Class I: A*33:03, A*24:02, B*07:02, B*44:03, B*52:01, C*03, C*16, C*12:02, C*14:03), (HLA Class II: DRB1*07, DRB1*01:01, DRB1*13:02, DRB1*15:02, DQA1*02, DQB1*03:02, DQB1*05:01, DQB1*06:04, DPB1*04:01, DPB1*09:01), Hashimoto Thyroiditis (HT) - HLA Risk Genotypes (HLA Class I: A*2, A*02:07), (HLA Class II: DRB1*03, DRB1*04, DRB1*04:03, DRB1*08, DRB4*01:01, DQA1*03, DQA1*03:011, DQA1*03:012, DQA1*04:01, DQB1*03:01, DQB1*03:04, DQB1*03:03, DQB1*04), HLA Protective Genotypes (HLA Class I: B*44:03, C*14:03), (HLA Class II: DRB1*07, DRB1*13, DRB1*13:02, DQA1*02:01, DQA1*01:02, DQA1*01:03, DQB1*06, DQB1*06:04, DPB1*04:01), IgA Nephropathy (IgAN) - HLA Risk Genotypes (HLA Class I: A*11:01, B*40:01), (HLA Class II: DQB*05:01, DQB1*03:01, DQA1*01:01, DQB*03:02), HLA Protective Genotypes (HLA Class II: DQA1*03:01, DQA1*03:02, DRB1*09:01, DQB1*03:03), Idiopathic Membranous Nephropathy (IMN) - HLA Risk Genotypes (HLA Class II: DRB1*03:01, DRB1*15:01, DRB3*02:02), HLA Protective Genotypes (HLA Class II: DQA1*03:01, DQA1*03:02, DRB1*09:01, DQB1*03:03), Lyme Borreliosis - HLA Risk Genotypes (HLA Class II: DRB1*01:01, DRB1*01:02, DRB1*03:05, DRB1*04:01, DRB1*04:02, DRB1*04:04, DRB1*04:05, DRB1*16:01, DRB1*17, DRB5*01:01), HLA Protective Genotypes (HLA Class II: DRB1*08:01, DRB1*11:01, DRB1*13), Multiple Sclerosis (MS) - HLA Risk Genotypes (HLA Class II: DRB1*15:01, DRB1*03:01, DQB1*06:02), HLA Protective Genotypes (HLA Class I: A*02:01), (HLA Class II: DRB1*01, DRB1*09, DRB1*11), Rheumatoid Arthritis (RA) - HLA Risk Genotypes (HLA Class II: High-risk shared epitope (SE) alleles: DRB1*04:01, DRB1*04:04, DRB1*10, DRB1*01:01, DRB1*04:05, DRB1*04:10, DRB1*01, Novel risk alleles: DPB1*04:01, DPB1*06:01), HLA Protective Genotypes (HLA Class II: DRB1*13:01, DRB1*13:02, DRB1*04:02, DRB1*11, DPB1*01:01, DPB1*04:02, DPB1*05:01), Systemic Lupus Erythematosus (SLE), HLA Risk Genotypes (HLA Class I: A*29, B*51), (HLA Class II: DQA1*01:02, DRB1*03:01, DRB1*15:01, DRB1*07, DRB1*08:01, DRB1*08:03, DRB1*09:01, DQB1*02, DQB1*06:02, DQB1*06, DQB1*03:01), HLA Protective Genotypes (HLA Class II: DRB1*13:02, DRB1*14:03, DRB1*11:01, DRB1*12:02, DRB1*16), Vitiligo - HLA Risk Genotypes (HLA Class I: A*02, A*33, A*33:01, B*13, B*27, B*44:03), (HLA Class II: DRB1*07:01), HLA Protective Genotypes (HLA Class I: A*09, B*18, B*35, B*52)

ABCG2 421C>A; ADRA2A C-1291G; ANKK1/DRD2 DRD2:Taq1A; BDNF 434C>T; COMT Val158Met; CYP1A2 *1F, *1K; CYP2B6 *6, *9, *11, *18; CYP2C19 *2, *3, *4, *4B, *6, *7, *8, *9, *10, *17; CYP2C9 *2, *3, *4, *5, *6, *8, *11, *27; CYP2D6 *2, *3, *4, *4M, *6, *7, *8, *9, *10, *12, *14A, *14B, *17, *29, *35, *41; CYP3A4 *3, *12, *17, *22; CYP3A5 *3, *3C, *6, *7; Factor II 20210G>A; Factor V Leiden 1691G>A; MTHFR1298A>C, 677C>T; OPRM1 A118G; SLCO1B1 521T>C; UGT2B15 *2; VKORC1 -1639G>A